|RedHill Biopharma Ltd -- USA Stock|| |
USD 6.28 0.05 0.80%
Chief Accounting Officer
Mr. Uri Hananel Aharon serves as Chief Accounting Officer at Redhill Biopharma Ltd, effective since 2012. His work experience includes the following roles Team Manager at Ernst Young Israel and Accounting Intern at Ziv Haft, BDO . He holds a Bachelors degree in Accounting and Economics from The Hebrew University of Jerusalem and a MBA degree, majoring in Business Taxation, from the College of Management Academic Studies, Rishon LeZion.
Age: 35 Executive Since 2011 MBA
972 3 541 3131 http://www.redhillbio.com
Aharon is a graduate of the Hebrew University and the Academic College for Management, Rishon Lezion .
The company has return on total asset (ROA)
of (58.73) %
which means that it has lost $58.73 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (116.81) %
meaning that it created substantial loss on money invested by shareholders.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, and cancer. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma is traded on Nasdaq Capital Markets in USA.RedHill Biopharma Ltd (RDHL) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 13 people. RedHill Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.